Reaction
Serous Retinal Detachment reporting signals
As of the last recalculation, Serous Retinal Detachment appears in 785 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is ENCORAFENIB (PRR 1,647.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Encorafenib | 345 | 1,647.4 | 1,707.2 |
| Cetuximab | 105 | 102.4 | 102.8 |
| Vemurafenib | 32 | 73.6 | 73.7 |
| Dabrafenib | 46 | 61.4 | 61.6 |
| Trametinib | 49 | 57.3 | 57.4 |
| Guanfacine | 11 | 37.6 | 37.6 |
| Ranibizumab | 34 | 35.5 | 35.5 |
| Ipilimumab | 49 | 32.0 | 32.1 |
| Tretinoin | 8 | 26.4 | 26.4 |
| Aflibercept | 27 | 23.7 | 23.7 |
| Amphetamine | 7 | 22.6 | 22.6 |
| Nivolumab | 71 | 21.3 | 21.3 |
| Faricimab | 6 | 19.8 | 19.8 |
| Triamcinolone Acetonide Ointment Usp, 0.05% | 14 | 16.1 | 16.1 |
| Diclofenac Potassium, Film Coated | 3 | 9.5 | 9.5 |
| Diclofenac Potassium Tablets | 3 | 9.5 | 9.5 |
| Atezolizumab | 12 | 8.3 | 8.3 |